Uterine perforation - 5-year experience in 3-d image guided gynaecological brachytherapy at institute of oncology ljubljana

Radiology and Oncology

Volumn 47, Issue 2, 2013, Pages 154-160

  Segedin, Barbara ^a   Gugic, Jasenka ^a   Petric, Primoz ^a,b  

^a INSTITUTE OF ONCOLOGY   (Slovenia)

^b National Center of Cancer Care and Research   (Qatar)

Author keywords

3d imaging; Brachytherapy; Ultrasound guidance; Uterine perforation

Indexed keywords

CISPLATIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BRACHYTHERAPY; CLINICAL FEATURE; CONSERVATIVE TREATMENT; ENDOMETRIUM CANCER; FEASIBILITY STUDY; FEMALE; GYNECOLOGIC CANCER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MYOMETRIUM; OVARY CANCER; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; THREE DIMENSIONAL IMAGING; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT DURATION; UTERINE CERVIX CANCER; UTERINE FUNDUS; UTERUS PERFORATION; VAGINA CARCINOMA;

EID: 84885005926     PISSN: 13182099     EISSN: 15813207     Source Type: Journal    
DOI: 10.2478/raon-2013-0030     Document Type: Article

References (38)

1. Kim RY, Levy DS, Brascho DJ, Hatch KD. Uterine perforation during intracavitary application. Prognostic significance in carcinoma of the cervix. Radiology 1983; 147; 249-51. (Pubitemid 13112356)
2. Corn BW, Shaktman BD, Lanciano RM, Hogan WM, Cater JR, Anderson L, et al. Intra- And perioperative complications associated with tandem and colpostat application for cervix cancer. Gynecol Oncol 1997; 64:224-9. (Pubitemid 27097569)
3. Jhingran A, Eifel PJ. Perioperative and postoperative complications of intracavitary radiation for FIGO stage l-lll carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000; 46:1177-83. (Pubitemid 30139428)
4. Granai CO, Doherty F, Allee P, Ball HG, Madoc-Jones H, Curry SL Ultrasound for diagnosing and preventing malplacement of intrauterine tandems. Obstet Gynecol 1990; 75:110-3. (Pubitemid 20047943)
5. Matsuyama T, Tsukamoto N, Matsukuma K, Kamura T, Jingu K. Uterine perforation at the time of brachytherapy for the carcinoma of the uterine cervix. Gynecol Oncol 1986; 23:205-11. (Pubitemid 16155036)
6. Barnes EA, Thomas G, Ackerman I, Barbera L, Letourneau, Lam K, et al. Prospective comparison of clinical and computed tomography assessment in detecting uterine perforation with intracavitary brachytherapy for carcinoma of the cervix. Int J Gynecol Cancer 2007; 17:821-6. (Pubitemid 47063335)
7. Irvin W, Rice L, Taylor P, Anderson W, Schneider B. Uterine perforation at the time of brachytherapy for carcinoma of the cervix. Gynecol Oncol 2003; 90:113-22. (Pubitemid 37338085)
8. Milman RM, Goodman P. Uterine perforation by an intracavitary tandem: CT demonstration. Clin Imaging 1991; 15:223-6.
9. Mills SE, Sugg NK, Mahnesmith RC Endometrial carcinoma with pelvic involvement following uterine perforation. Diagn Gynecol Obstet 1981; 3: 149-54. (Pubitemid 11085326)
10. Corn BW, Hanlon AL, Pajak TF, Owen J, Hanks GE. Technically accurate intracavitary insertions improve pelvic control among patients with locally advanced carcinoma of the uterine cervix. Gynecol Oncol 1994, 53:294-300. (Pubitemid 24187856)
11. Petric P, Hudej R, Marolt-Music M. MRI-based brachytherapy for cervical cancer. Onkologija 2008; 12:46-51.
12. Petric P. Moving from 2D to 3D brachytherapy in gynecological tumors. J Contemp Brachyther 2011; 3:161-2.
13. Petric P, Hudej R, Segedin B, Zobec Logar HB. MRI assisted treatment planning improves the DVH parameters in cervix cancer brachytherapy. Radiother Oncol 2011; 99:264-5.
14. Petric P, Hudej R, Rogelj P, Bias M, Segedin B, Zobec logar HB, et al. Comparison of 3D MRI with high sampling efficiency and 2D multiplanar MRI for contouring in cervix cancer brachytherapy. Radiol Oncol 2012; 46-242-51.
15. Petric P, Dimopoulos JCA, Kirisits C, Berger D, Hudej R, Potter R. Inter- And in- traobserver variation in HR-CTV contouring: intercomparison of transverse and paratransverse image orientation in 3D-MRI assisted cervix cancer brachytherapy. Radiother Oncol 2008; 89:164-71.
16. Haie-Meder C, Potter R, Van Umbergen E, Briot E, De Brabandere M, Dimopoulos JCA, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005; 74:235-45. (Pubitemid 40349132)
17. Potter R, Haie-Mader C, Van Umbergen E, Barillot I, De Brabandere M, Dimopoulos J, et al. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006; 78:67-77. (Pubitemid 43131038)
18. Petric P, Potter R, Van Umbergen E, Haie-Meder C Adaptive contouring of the target volume and organs at risk. In: Viswanathan AN, Kristis C, Erickson BE, Potter R, editors. Gynecologic radiation therapy, novel approaches to image-guidance and management. Berlin Heidelberg: Springer Verlag; 2011. p. 99-118.
19. Gerbaulet A, Potter R, Haie-Meder C. Cervix cancer. In: Gerbaulet A, Potter R, Mazeron JJ, Meertens H, Van Umbergen E, editors. The GEC ESTRO handbook of brachytherapy. Brussels: European Society of Therapeutic Radiology and Oncology; 2002. p. 301-63.
20. Petric P, Hudej R, Marolt-Music M. MRI assisted cervix cancer brachytherapy pre-planning, based on insertion of the applicator in para-cervical anaesthesia: preliminary results of a prospective study. J Contemp Brachyther 2009; 1:163-9.
21. Dimopoulos JCA, Kirisits C, Petric P, Georg P, Lang S, Berger D, et al. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results. Int J Radiat Oncol Biol Phys 2006, 66:83-90. (Pubitemid 44175668)
22. Petric P, Hudej R, Rogelj P, Lindegaard I, Tanderup K, Kirisits C, et al. Frequency-distribution mapping of HR CTV in cervix cancer: possibilities and limitations of existent and prototype applicators. Radiother Oncol 2010; 96:70.
23. Makin WP, Hunter, RD. CT scanning in intracavitary therapy: Unexpected findings in "straightforward" insertions. Radiother Oncol 1988; 13:253-5. (Pubitemid 19009240)
24. Davidson MTM, Yuen J, D'Souza DP, Radwan JS, Hammond JA, Batchelar DL Optimization of high-dose-rate cervix brachytherapy applicator placement: The benefits of intraoperative ultrasound guidance. Brachytherapy 2008; 7:248-53. (Pubitemid 351957934)
25. Brascho DJ. Use of pelvic pneumography in planning radiotherapy of endometrial carcinoma. Radiology 1970; 97:113-20.
26. Scott WP. Tandem hysterography during intrauterine radium application. Am J Roentgenol Radium Ther Nucl Med 1975; 124:636-7.
27. Potter R, Dimopoulos J, Georg P, Lang S, WaldhSusI C, Wachter-Gerstner N, et al. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 2007, 83:148-55. (Pubitemid 46783926)
28. Haie-Meder C, Chargari C, Rey A, Dumas I, Morice P, Magnc N. MRI-based low dose-rate brachytherapy experience in locally advanced cervical cancer patients initially treated by concomitant chemoradiotherapy. Radiother Oncol 2010; 96:161-5.
29. De Brabandere M, Mousa AG, Nulens A, Swinnen A, Van Umbergen E. Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma. Radiother Oncol 2008; 88:217-26.
30. Lindegaard JC, Tanderup K, Nielsen SK, Haack S, Gelineck J. MRI-guided 3D optimization significantly pmproves DVH Parameters of pulsed-dose-rate brachytherapy in locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2008; 71:756-64.
31. Potter R, Georg P, Dimopoulos J, Grimm M, Berger D, Nesvacil N, et al. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer. Radiother Oncol 2011; 100:116-23.
32. Jurgenliemk-Schulz IM, Tersteeg RJ, Roesink JM, Bijmolt S, Nomden CN, Moerland MA, et al. MRI-guided treatment-planning optimisation in intracavitary or combined intracavitary/interstitiai PDR brachytherapy using tandem ovoid applicators in locally advanced cervical cancer. Radiother Oncol 2009; 93:322-30.
33. Granai CO, Allee P, Doherty F, Madoc-Jones H, Curry SL Ultrasound used for assessing the in situ position of intrauterine tandems. Gynecol Oncol 1984; 18:334-8. (Pubitemid 14095033)
34. Granai CO, Allee P, Doherty F, Ball HG, Madoc-Jones H, Curry SL Intraperative real-time ultrasonography during intrauterine tandem placement. Obstet Gynecol 1986; 67:112-4. (Pubitemid 16174311)
35. Wong F, Bhimji S. The usefulness of ultrasonography in intracavitary radiotherapy using selectron applicators. Int J Radiat Oncol Biol Phys 1990; 19:477-82. (Pubitemid 20299044)
36. Tanaka S, Hishikawa Y, Kamikonya N, Miura T. Sonographic positioning of endouterine applicator. Radiat Med 1987; 5:92-3.
37. Fleischer AC, Burnett LS, Murray MJ, Jones HW. Intraoperative guidance for intrauterine procedures with transrectal sonography. Radiology 1990; 176:576-7. (Pubitemid 20225160)
38. Sharma DN, Rath GK, Thulkar S, Kumar S, Subramani V, Julka PK. Use of transrectal ultrasound for high dose rate interstitial brachytherapy for patients of carcinoma of uterine cervix. J Gynecol Oncol 2010; 21:12-7.